The study was published in Infection Control & Hospital Epidemiology. The researchers who authored the study argue examining the association between hospital-onset bacteremia, or any positive blood culture obtained 48 hours post admission, and CLABSI rates can be useful.
By comparing the power of hospital-onset bacteremia and CLABSI rates, the researchers were able to discriminate quality among intensive care units at different hospitals using standardized infection ratios with 95 percent confidence intervals.
Using data collected from 80 ICUs from 16 U.S. and Canadian hospitals, the researchers identified a total of 663 CLABSIs, 475,420 central line days, 11,280 hospital-onset bacteremia, and 966,757 patient days. They found an absolute change in hospital-onset bacteremia of one per 1,000 patient days was associated with a 2.5 percent change in CLABSI rate.
Ultimately, the researchers concluded, “Change in [hospital-onset bacteremia] rate is strongly associated with change in CLABSI rate and has greater power to discriminate between ICU performances. Consideration should be given to using [hospital-onset bacteremia] to replace CLABSI as an outcome measure in infection prevention quality assessments.”
More articles on quality measures:
Measuring quality performance: 4 biggest challenges rural hospitals face
How 9 hospitals responded to Consumer Reports ratings as worst in the country
8 ways to estimate the incidence of diagnostic errors
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
